|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net (loss) income | |||||
| Credit loss expense | |||||
| Depreciation and amortization | |||||
| Gain on sale of assets | |||||
| Depreciation | |||||
| Amortization of right-of-use asset | |||||
| Provision for product warranties | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid inventory | |||||
| Other current assets | |||||
| Other noncurrent assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liability | |||||
| Income tax payable | |||||
| Deferred revenue | |||||
| Product warranties | |||||
| Total adjustments | |||||
| Net cash provided by (used in) operating activities | |||||
| Acquisition of property and equipment | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Repurchase of common stock | |||||
| Withholding taxes on stock-based compensation | |||||
| Exercise of stock options | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of period | |||||
| Cash and cash equivalents – end of period | |||||
| Income tax paid | |||||
| Income tax refunds received | |||||
| Supplemental schedule of noncash investing and financing transactions: | |||||
| Transfer of inventory to property and equipment | |||||
| Net transfers from inventory to fixed assets | |||||
| Lease liability arising from obtaining right-of-use-assets | |||||
Loading...